Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs
Published: 26 October 2022
10m 50sPart 5 | Session 1 Chapter 4 - Video Duration: 10m 50s
17m 40sPart 6 | Session 1 Chapter 5 - Video Duration: 17m 40s
5m 30sPart 1 | Session 1 Chapter 1 - Video Duration: 5m 30s Javed Butler, Clyde W Yancy, Faiez Zannad, Christiane Angermann
10m 2sPart 2 | Session 1 Chapter 2.1 - Video Duration: 9m 58s Christiane Angermann
8m 42sPart 3 | Session 1 Chapter 2.2 - Video Duration: 8m 42s Javed Butler, Clyde W Yancy, Faiez Zannad, Christiane Angermann
During this broadcast, "Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs", Radcliffe Medical Education brings together a globally-renowned European and American faculty to participate in a roundtable discussion. The aim: to provide both a reflection on the HF landscape following published data at congress and to examine what future developments can be expected at forthcoming events via lively discussion and data presentations.
Dr Javed Butler (University of Mississippi Medical Center, US) leads proceedings, and is joined by Dr Clyde Yancy (Northwestern University Feinberg School of Medicine, US), Prof Faiez Zannad (Academic Hospital (CHU), Nancy, FR), and Prof Christiane Angermann (University Hospital of Würzburg, Würzburg, DE) for an insightful presentation and a discussion.
Upon participation in the roundtable discussion physicians will be able to:
- Recall the utility of EF in heart failure treatment, patient selection and treatment response
- Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy
- Incorporate quality of life measures for assessing therapeutic efficacy in HF
- Recall outcomes from heart failure trials from recent congress and publications and their impact on practice
This programme is intended to educate:
- Global Heart Failure Physicians
- General Cardiologists
More from this programme
How Is the Landscape of HF Changing?
A Changing Paradigm in the Progression of HF Therapy Initiation
An ESC 2022 Update: Relevant New Medical Data
Applying the Guidelines in Clinical Practice
Professor of Therapeutics and Cardiology, Head of CIC
Dr Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU).
Dr Zannad is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension.
Dr Zannad is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.